Skip to main navigation Skip to search Skip to main content

Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents

  • D Suez
  • , G Krivan
  • , S Jolles
  • , M Stein
  • , S Gupta
  • , K Paris
  • , P.M. van Hagen
  • , N Brodszki
  • , W Engl
  • , H Leibl
  • , B McCoy
  • , L Yel

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1057-1065
Number of pages9
JournalImmunotherapy
Volume11
Issue number12
DOIs
Publication statusPublished - 2019

Research programs

  • EMC OR-01

Cite this